Showing results (1661-1670 of 1,945) with videos related to

Sort By:
Pageof 195
Environmental Microbiology|August 4, 2021
The bacterium Pseudomonas protegens antagonizes the microalga Chlamydomonas reinhardtii using a blend of toxinsMagdalena M Rose, Daniel Scheer, Yu Hou, et al.
Bone Marrow Transplantation|April 1, 1999
A phase I study of paclitaxel for mobilization of peripheral blood progenitor cellsB A Burtness, A Psyrri, M Rose, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 7, 2020
Evaluating Use Cases for Human Challenge Trials in Accelerating SARS-CoV-2 Vaccine DevelopmentLinh Chi Nguyen, Christopher W Bakerlee, T Greg McKelvey, et al.
Nature Communications|November 21, 2019
Transposable element expression in tumors is associated with immune infiltration and increased antigenicityYu Kong, Christopher M Rose, Ashley A Cass, et al.
Oncotarget|March 28, 2018
Reduced SMAD2/3 activation independently predicts increased depth of human cutaneous squamous cell carcinomaAidan M Rose, Lindsay C Spender, Christopher Stephen, et al.
Biochemistry|February 27, 1996
Mutational analysis of the endothelin type A receptor (ETA): interactions and model of selective ETA antagonist BMS-182874 with putative ETA receptor binding cavityM L Webb, P S Patel, P M Rose, et al.
Lancet (London, England)|March 20, 1982
Adult T-cell lymphoma-leukaemia in Blacks from the West IndiesD Catovsky, M F Greaves, M Rose, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 3, 2014
Reproductive and hormonal risk factors for antinuclear antibodies (ANA) in a representative sample of U.S. womenChristine G Parks, Frederick W Miller, Minoru Satoh, et al.
Cells|July 11, 2025
COP1 Deficiency in BRAF<sup>V600E</sup> Melanomas Confers Resistance to Inhibitors of the MAPK PathwayAda Ndoja, Christopher M Rose, Eva Lin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2006
Cutting edge: B and T lymphocyte attenuator and programmed death receptor-1 inhibitory receptors are required for termination of acute allergic airway inflammationChristine Deppong, Twyla I Juehne, Michelle Hurchla, et al.
Pageof 195